Ultrasonography for Nutritional Assesment in Cirrhotic Patients
RFATCP
Ultrasonography of Rectus Femoris and Anterior Tibialis Muscles for Nutritional Assesment in Cirrhotic Patients
1 other identifier
observational
72
1 country
1
Brief Summary
Ultrasonography of Rectus Femoris and Anterior Tibialis muscles for nutritional assesment in cirrhotic patients undergoing major abdominal surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 24, 2019
CompletedFirst Posted
Study publicly available on registry
September 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2021
CompletedAugust 21, 2020
August 1, 2020
1.3 years
April 24, 2019
August 20, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement of the diameters of the Rectus Femoris and Anterior Tibialis muscles using the ultrasound in cm and the change of these diameters over the postoperative period till the 7th day to assess nutrition status in cirrhotic patients
observational prospective study
perioperative days 1,3,5,7
Interventions
Ultrasound is a type of imaging. It uses high-frequency sound waves to look at organs and structures inside the body.
Eligibility Criteria
cirrhotic patients child A,B
You may qualify if:
- hepatic patients classified as child A, B undergoing major abdominal surgery (liver resection,whipple,Splenectomy,colectomy, Common Bile Duct exploration,By pass surgery)
- yrs old
- no past history of nutritional problems,chronic use of drugs,patients with no orthopedic issues such as skeletal fractures or immobilization
You may not qualify if:
- Refusal of the patient to share in the study, relevant comorbidities (renal, heart disease or COPD)
- previous immune abnormalities including treatment with corticosteroids
- neuromuscular diseases
- laparoscopic surgery
- patients on parenteral nutrition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Liver Institute
Shibīn al Kawm, Menoufia, 2345, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amany A. Zayd, MBBCH
Department of Anesthesia NLI
- STUDY DIRECTOR
Eman S. Ibrahim, MD
National Liver Institute
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2019
First Posted
September 23, 2019
Study Start
April 1, 2019
Primary Completion
July 1, 2020
Study Completion
April 1, 2021
Last Updated
August 21, 2020
Record last verified: 2020-08